Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer

British Journal of Cancer

Volumn 76, Issue 10, 1997, Pages 1293-1299

  Kopreski, M S ^a   Benko, F A ^a   Kwee, C ^a   Leitzel, K E ^a   Eskander, E ^a   Lipton, A ^a   Gocke, C D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Colorectal cancer; DNA; K ras; Plasma; Polymerase chain reaction; Serum

Indexed keywords

DNA; GELATIN; SODIUM CHLORIDE;

ARTICLE; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER SURGERY; COLORECTAL CANCER; CONTROLLED STUDY; DNA SEQUENCE; GENE MUTATION; HUMAN; MONITORING; ONCOGENE K RAS; PLASMA; POLYMERASE CHAIN REACTION; PRECIPITATION; PRIORITY JOURNAL; SERUM;

EID: 0030724379     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.551     Document Type: Article

References (39)

1. Aggarwal SK, Wagner RW, McAllister PK and Rosenberg B (1975) Cell-surface-associated nucleic acid in lumorigenic cells made visible with platinume-pyrimidine complexes by electron microscopy. Proc Natl Acad Sci USA 72: 928-932
2. Anker P, Stroun M and Maurice PA (1975) Spontaneous release of DNA by human bood lymphocytes as shown in an in vitro system. Cancer Res 35: 2375-2382
3. Beutler E. Gelbart T and Kuhl W (1990) Interference of heparin with the polymerase chain reaction. Biotechniques 9: 166
4. Bocker T, Schlegel J, Kullmann E, Stumm G, Zirngibl H, Epplen JT and Ruschoff J (1996) Genomic instability in colorectal carcinomas: comparison of different evaluation methods and their biological significance. J Pathol 179: 15-19
5. Bos JL. (1989) Ras oncogenes in human cancer: A review. Cancer Res 49: 4682-4689
6. Bos JL, Fearon ER, Hamilton SR, Vries, MV, van Boom JH, van der Eb AJ and Vogelstein B (1987) Prevalence of ras gene mutations in human colorectal cancers. Nature 327: 293-297
7. Chen XQ, Stroun M, Magnenat JL, Nieod LP, Kurt AM, Lyautey J, Lederrey C and Anker P (1996) Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nature Med 2: 1033-1035
8. Datla YH, Adams PT, Drobyski WR, Ethier S, Terry VH and Roth MS (1994) Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol 12: 475-482
9. Fedorov NA, Yaneva IS, Skotnikova OI and Pan'kov VN (1986) DNA assay in human blood plasma. Bull Exp Biol Med 102: 1190-1192
10. Forrester K, Almonguera C, Han K, Grizzle, WE and Perucho M (1987) Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 327: 298-303
11. Fournie GJ, Gayral-Taminh M, Bouche J-P and Conte JJ (1986) Recovery of nanogram quantities of DNA from plasma and quantitative measurement using labelling by nick translation. Anal Biochem 158: 250-256
12. Ghossein RA, Scher HI, Gerald WI, Kelly WK, Curley T, Amsterdam A, Zhang Z.-F and Rosai J (1995) Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications. J Clin Oncol 13: 1195-1200
13. Gribben JG, Neuberg D, Barber M, Moore J, Pesek KW, Freedman AS and Nadler LM (1994) Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow. Blood 83: 3800-3807
14. Hardingham JE, Kotasek D, Sage RE, Eaton MC, Pascoe VH and Dobrovic A (1995) Detection of circulating tumor cells in colorectal cancer by immunobead-PCR is a sensitive prognostic marker for relapse of disease. Mol Med 1: 789-794
15. Hoon DSB, Wang Y, Dale PS, Conrad AJ, Schmid P, Garrison D, Kuo C, Foshag LJ, Nizze AJ and Morton DI. (1995) Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J Clin Oncol 13: 2109-2116
16. Juckelt DA and Rosenberg B (1982) Actions of cis-diamminedichloroplatinum on cell surface nucleic acids in cancer cells as determined by cell electrophoresis techniques. Cancer Res 42: 3565-3573
17. Kahn SM, Jiang W, Culbertson TA, Weinstein IB, Williams GM, Tomita N and Ronai Z (1991) Rapid and sensitive nonradioactive detection of mutant K-ras genes via 'enriched' PCR amplification. Oncogene 6: 1079-1083
18. Komeda T, Fukuda Y, Sando T, Kita R, Furukawa M, Nishida N, Amenomori M and Nakao K (1995) Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood. Cancer 75: 2214-2219
19. Kwok S and Higuchi R (1989) Avoiding false positives with PCR. Nature 339: 237-238
20. Leon SA, Shapiro B. Sklaroff DM and Yaros MJ (1977) Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 37: 646-650
21. Leon SA, Shapiro B, Servi P and Parsons RG (1981) A comparison of DNA and DNA-binding protein levels in malignant disease. Eur J Cancer 17: 533-538
22. Lothe RA, Peltomäki P, Meling GI, Aaltonen LA, Nyström-Lahti M. Pylkkänen L, Heimdal K, Andersen TI, Moller P, Rognum T, Fossa SD, Haldorsen T, Langmark F, Brogger A, de la Chapelle A and Borresen A-L (1993) Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res 53: 5849-5852
23. Moreno JG, Croce CM, Fischer R, Monne M, Vihko P, Mulholland SG and Gomella LG (1992) Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res 52: 6110-6112
24. Nawroz H, Koch W, Anker P, Stroun M and Sidransky D (1996) Microsatellite alterations in serum DNA of head and neck cancer patients. Nature Med 2: 1035-1037
25. Oudejans JJ. Slebos RJC, Zoetmulder FAN, Moor WJ and Rodenhuis S (1991) Differential activation of ras genes by point mutation in human colon cancer with metastases to either lung or liver. Int J Cancer 49: 875-879
26. Pichert G, Alyea EP, Soiffer RJ, Roy D-C and Ritz J (1994) Persistence of myeloid progenitor cells expressing BCR-ABL mRNA after allogeneic bone marrow transplantation for chronic myelogenous leukemia. Blood 84: 2109-2114
27. Rogers JC, Boldt D, Kornfeld S, Skinner A and Valeri CR (1972) Excretion of deoxyribonucleic acid by lymphocytes stimulated with phytohemagglutinin or antigen. Proc Natl Acad Sci USA 69: 1685-1689
28. Shapiro B, Chakrabarty M, Cohn EM and Leon SA (1983) Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease. Cancer 51: 2116-2120
29. Sidransky D, Tokino T, Hamilton SR, Kinzler KW, Levin B, Frost P and Vogelstein B (1992) Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 256: 102-105
30. Smith B, Selby P, Southgate J, Pittman K, Bradley C and Blair GE (1991) Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 338: 1227-1229
31. Sorenson GD, Pribish DM, Valone FH, Memoli VA, Bzik DJ and Yao S-L (1994) Soluble normal and mutated DNA sequences from single-copy genes in human blood. Cancer Epidemiol Biomarkers Prev 3: 67-71
32. Stroun M, Anker P, Maurice PA and Gahan PB (1977) Circulating nucleic acids in higher organisms. Int Rev Cytol 51: 1-48
33. Stroun M, Anker P, Lyautey J, Lederrey C and Maurice PA (1987) Isolation and characterization of DNA from the plasma of cancer patients. Eur J Cancer Clin Oncol 23: 707-712
34. Stroun M, Anker P, Maurice P, Lyautey J, Lederrey C and Beljanski M (1989) Neoplaslic characteristics of the DNA found in the plasma of cancer patients. Oncology 46: 318-322
35. Tada M, Omata M, Kawai S, Saisho H, Ohto M, Saiki R and Sninsky JJ (1993) Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res 53: 2472-2474
36. Vasioukhin V, Anker P, Maurice P, Lyautey J, Lederrey C and Stroun M (1994) Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia. Br J Haematol 86: 774-779
37. Vasyukhin V, Stroun M, Maurice P, Lyautey J, Lederrey C and Anker P (1994) K-ras point mutations in the blood plasma DNA of patients with colorectal tumors. In Challenges of Modern Medicine, Volume 5, Biotechnology Today, Verna R and Shamoo A (eds) pp. 141-150. Area-Serono Symposia Publications: Rome
38. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AMM and Bos JL (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319: 525-532
39. Yakubovskaya MS, Spiegelman V, Luo FC, Malaev S, Salney A, Zborovskaya I, Gasparyan A, Polotsky B, Machaladze Z, Trachtenberg AC, Belitsky GA and Ronai Z (1995) High frequency of K-ras mutations in normal appearing lung tissues and sputum of patients with lung cancer. Int J Cancer 63: 810-814